Proscia

Proscia is a digital pathology company headquartered in Philadelphia, PA, with a European HQ in Sligo, Ireland. The company provides digital pathology solutions for life sciences and anatomic pathology, offering a range of products such as the Concentriq Enterprise Pathology Platform, Concentriq for Research, Concentriq AP, AI Applications, Automated QC, Derm AI, and Real-World Data. Proscia’s Concentriq AP-Dx has received FDA 510(k) clearance for primary diagnosis in the United States. The company’s Concentriq platform connects entire pathology ecosystems by integrating with all technology, offering flexibility and investment protection. Proscia partners with leading pharmaceutical and biotech companies to advance milestones through access and insights from diverse, multimodal real-world data. The company collaborates with over 12 clinical AI partners and has access to more than 1 million whole slide images for AI research. Proscia’s solutions integrate with all major whole slide image scanners and LIS applications. To date, Proscia has raised $72 million.